
@Article{,
AUTHOR = {Camden Hebson, Wendy Book, Robert W. Elder, Ryan Ford, Maan Jokhadar, Kirk Kanter, Brian Kogon, Adrienne H. Kovacs, Rebecca D. Levit, Michael Lloyd, Kevin Maher, Preeti Reshamwala, Fred Rodriguez III, Rene Romero, Thor Tejada, Anne Marie Valente, Gruschen Veldtman, Michael McConnell},
TITLE = {“Frontiers in Fontan failure: A summary of conference proceedings”},
JOURNAL = {Structural and Congenital Heart Disease},
VOLUME = {12},
YEAR = {2017},
NUMBER = {1},
PAGES = {6--16},
URL = {http://www.techscience.com/schd/v12n1/38725},
ISSN = {3071-1738},
ABSTRACT = {“Frontiers in Fontan Failure” was the title of a 2015 conference sponsored by Children’s Healthcare of Atlanta and Emory University School of Medicine. In what is hoped to be the first of many
such gatherings, speakers and attendees gathered to discuss the problem of long-term clinical
deterioration in these patients. Specific focuses included properly defining the problem and then
discussing different treatment strategies, both medical and surgical. The health of the liver after
Fontan palliation was a particular point of emphasis, as were quality of life and future directions.},
DOI = {}
}



